SPRC vs. PRFX, TMBR, HSTO, THAR, AGRX, CYCC, CWBR, PXMD, SLRX, and SEEL
Should you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include PainReform (PRFX), Timber Pharmaceuticals (TMBR), Histogen (HSTO), Tharimmune (THAR), Agile Therapeutics (AGRX), Cyclacel Pharmaceuticals (CYCC), CohBar (CWBR), PaxMedica (PXMD), Salarius Pharmaceuticals (SLRX), and Seelos Therapeutics (SEEL). These companies are all part of the "pharmaceutical preparations" industry.
SciSparc (NASDAQ:SPRC) and PainReform (NASDAQ:PRFX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability, community ranking and valuation.
SciSparc has higher revenue and earnings than PainReform.
In the previous week, SciSparc and SciSparc both had 2 articles in the media. SciSparc's average media sentiment score of 1.44 beat PainReform's score of 1.43 indicating that SciSparc is being referred to more favorably in the media.
SciSparc has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, PainReform has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
SciSparc and PainReform both received 2 outperform votes by MarketBeat users. However, 100.00% of users gave PainReform an outperform vote while only 66.67% of users gave SciSparc an outperform vote.
25.1% of SciSparc shares are owned by institutional investors. Comparatively, 37.3% of PainReform shares are owned by institutional investors. 1.5% of SciSparc shares are owned by insiders. Comparatively, 34.4% of PainReform shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
PainReform beats SciSparc on 4 of the 7 factors compared between the two stocks.
Get SciSparc News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SPRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SciSparc Competitors List
Related Companies and Tools
